NOVEMBER - 20216Managing EditorAlex D'souzaEditorial StaffVisualizerDavid JohnJaxon JaseSalesAndrew D'Souzaandrew.dsouza@medicaltechoutlook.com510.996.5123Joshua Parker Merlin WatsonJoe Philip Laura PintoNOVEMBER - 08 - 2021, volume 05 - Issue 16 (ISSN 2691-4093) Published by ValleyMedia, Inc. Emailsales@medicaltechoutlook.comeditor@medicaltechoutlook.commarketing@medicaltechoutlook.comTo subscribe to Medical Tech OutlookVisit www.medicaltechoutlook.com Copyright © 2021 ValleyMedia Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.*Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffAlex D'souzaManaging Editoreditor@medicaltechoutlook.comThe social importance of IVD is substantial. All the more so, since it can also be used to detect all sorts of diseases and potential new viruses, such as the novel coronavirus. Therefore, IVDs are of significant value to the general public. They are deemed indispensable tools of medical diagnoses and decision-making aids for disease prevention and timely treatment--enhancing wellbeing and keeping healthcare costs under check. In addition, IVDs are also one of the vital aids that address the needs of governments, payers, and patients by delivering optimal, individualized, and affordable treatments. These factors and rapid technological developments are now driving the evolution of IVD devices.Avant-garde IVD tools are allowing for rapid testing. Compared to traditional diagnostic tests that only capture a `snapshot' view of a patient at a given duration, the latest IVD tools are providing a much bigger and more robust data set for better clinical decision-making. Further, two emerging segments of IVDs--companion diagnostics and next-generation sequencing techniques--are expected to contribute to the growth of IVD technologies in the coming months.At this juncture, there is a wide range of established and emerging IVD solution providers that are offering the latest technologies best suited for the next generation of IVD needs. In this edition of MedTech Outlook, we bring you the story of some of the best-of-breed IVD solution providers that deliver the best outcomes for their clients. This edition also offers a combination of thought leadership from subject matter experts and exclusive insights from CXOs. We hope this edition will provide you with the proper assistance in choosing the best IVD solution providers according to your requirements. Let us know your thoughts!Preparing for the Next Stage of In Vitro Diagnostics Sarah FernandesEDITORIAL
< Page 5 | Page 7 >